US MRSA Drugs Market Forecast: Growth Drivers and Emerging Opportunities Through 2034
In the United States, methicillin-resistant Staphylococcus aureus (MRSA) remains an important cause of both healthcare-associated and community-associated infections, including skin and soft-tissue infections, bloodstream infections, pneumonia, and surgical-site infections. The continued presence of antimicrobial resistance, together with the need to manage severe and...
0 Comments 0 Shares 65 Views 0 Reviews